These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11114505)

  • 1. AB(5) toxins: structures and inhibitor design.
    Fan E; Merritt EA; Verlinde CL; Hol WG
    Curr Opin Struct Biol; 2000 Dec; 10(6):680-6. PubMed ID: 11114505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent Inhibitors of Channel-Forming Bacterial Toxins.
    Yamini G; Nestorovich EM
    Curr Top Microbiol Immunol; 2017; 406():199-227. PubMed ID: 27469304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting bacterial toxins by channel blockage.
    Bezrukov SM; Nestorovich EM
    Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyvalency: a promising strategy for drug design.
    Vance D; Shah M; Joshi A; Kane RS
    Biotechnol Bioeng; 2008 Oct; 101(3):429-34. PubMed ID: 18727104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands.
    Kitov PI; Sadowska JM; Mulvey G; Armstrong GD; Ling H; Pannu NS; Read RJ; Bundle DR
    Nature; 2000 Feb; 403(6770):669-72. PubMed ID: 10688205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combating infectious diseases through multivalent design.
    Fan E; Merritt EA
    Curr Drug Targets Infect Disord; 2002 Jun; 2(2):161-7. PubMed ID: 12462146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.
    Maize KM; Kurbanov EK; De La Mora-Rey T; Geders TW; Hwang DJ; Walters MA; Johnson RL; Amin EA; Finzel BC
    Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2813-22. PubMed ID: 25372673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced expansion of the S1' site in the anthrax toxin lethal factor.
    Maize KM; Kurbanov EK; Johnson RL; Amin EA; Finzel BC
    FEBS Lett; 2015 Dec; 589(24 Pt B):3836-41. PubMed ID: 26578066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial ADP-ribosylating toxins: molecular structures and signal transducing functions.
    Kato I
    Microbiol Immunol; 1991; 35(5):349-59. PubMed ID: 1943847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the structures and modes of action of bacterial toxins.
    Lacy DB; Stevens RC
    Curr Opin Struct Biol; 1998 Dec; 8(6):778-84. PubMed ID: 9914258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossing the hydrophobic barrier: insertion of membrane proteins.
    Engelman DM
    Science; 1996 Dec; 274(5294):1850-1. PubMed ID: 8984645
    [No Abstract]   [Full Text] [Related]  

  • 12. AB5 toxins.
    Merritt EA; Hol WG
    Curr Opin Struct Biol; 1995 Apr; 5(2):165-71. PubMed ID: 7648317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative structure-function analysis of active-site inhibitors of Vibrio cholerae cholix toxin.
    Lugo MR; Merrill AR
    J Mol Recognit; 2015 Sep; 28(9):539-52. PubMed ID: 25756608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial toxin inhibitors based on multivalent scaffolds.
    Branson TR; Turnbull WB
    Chem Soc Rev; 2013 Jun; 42(11):4613-22. PubMed ID: 23263178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Channel-forming toxins: tales of transformation.
    Gouaux E
    Curr Opin Struct Biol; 1997 Aug; 7(4):566-73. PubMed ID: 9266180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the glucosyltransferase activity of clostridial Rho/Ras-glucosylating toxins by castanospermine.
    Jank T; Ziegler MO; Schulz GE; Aktories K
    FEBS Lett; 2008 Jun; 582(15):2277-82. PubMed ID: 18505687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, biological functions and applications of the AB5 toxins.
    Beddoe T; Paton AW; Le Nours J; Rossjohn J; Paton JC
    Trends Biochem Sci; 2010 Jul; 35(7):411-8. PubMed ID: 20202851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AB5 ADP-ribosylating toxins: comparative anatomy and physiology.
    Burnette WN
    Structure; 1994 Mar; 2(3):151-8. PubMed ID: 8069630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.